In recent years, it’s been estimated that 10% to 28% of patients with myeloid disorders develop adult onset inflammatory and autoimmune disorders (IADs), complicating treatment. Treatment with Janus ...
Less than half of pregnant women with opioid use disorder (OUD) receive medications for OUD (MOUD) during pregnancy.
As our understanding of the neurobiology of addiction evolves, so do opportunities to develop more precise, brain-based interventions for co-occurring disorders. In our free webinar, “Advancing ...
Pregnant women with opioid use disorder were less likely to receive medication for opioid use disorder treatment during pregnancy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results